Richard, M <br/><br/>
Abnormal uptake of Tc-99m MIBI, a novel myocardial imaging agent, in the lungs of patients with systemic sclerosis.  [electronic resource] 

 -  Clinical nuclear medicine  Jan 1998 
 - 19-25 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0363-9762 
<br/><br/><label>Standard No.: </label>10.1097/00003072-199801000-00007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Coronary Disease--diagnostic imaging<br/>Dyspnea--physiopathology<br/>Endothelium, Vascular--metabolism<br/>Female<br/>Fibroblasts--metabolism<br/>Heart--diagnostic imaging<br/>Humans<br/>Injections, Intravenous<br/>Lung--diagnostic imaging<br/>Lung Diseases, Interstitial--diagnostic imaging<br/>Male<br/>Middle Aged<br/>Mitochondria--metabolism<br/>Pilot Projects<br/>Pulmonary Diffusing Capacity--physiology<br/>Pulmonary Fibrosis--diagnostic imaging<br/>Radionuclide Imaging<br/>Radiopharmaceuticals--administration & dosage<br/>Scleroderma, Systemic--diagnostic imaging<br/>Sensitivity and Specificity<br/>Technetium Tc 99m Sestamibi--administration & dosage<br/>Total Lung Capacity--physiology<br/>Vital Capacity--physiology